News & Events
In the news
New Webinar
GMP cell banking: one-stop-shop solution to speed up your project.
The newest edition of our webinar series will feature a discussion led by Lucy THULOT (Head of Manufacturing department) and Gaëtan BLAIZE (Business Development Manager) both part of Clean Cells. It will take place next 1st February and will explore the following theme : “GMP cell banking: one-stop-shop solution to speed up your project”.
The quarterly scientific journal
Clean Mails
Here is the last edition of our quarterly Clean Mails newsletter, having as main subject: "BSL3 GMP manufacturing suite". To read about this and find out Clean Cells, Naobios and Biodextris’ news or to receive our next editions, click here.
Upstream process optimization of bacteriophage production
using Design of Experiment
Clean Cells’ process development department has worked on implementing a robust and flexible Design of Experiment approach for upstream process optimization leading to higher titers and the characterization of a design space.
Congress
Meet our teams at CPHI Worldwide
Meet the teams from companies Clean Cells & Naobios next November as they attend CPHI Worldwide.
New Webinar
Veterinary framework: from regulation to GMP characterization of biologics
The theme of this new webinar will be « Veterinary framework : from regulation to GMP characterization of biologics » and will take place on 7th October 2021.
The quarterly scientific journal
Clean Mails
Here is the fourth edition of our quarterly Clean Mails newsletter, having as main subject: "Implementing digital PCR : a quality leap for the quantification of nucleic acids". To read about this and find out Clean Cells, Naobios and Biodextris’ news or to receive our next editions, click here.
Patent for potency assay evaluating cytolytic activity
Potency evaluation of cytolytic activity: cutting-edge innovation for your product
Our assay development team at Clean Cells continuously works on innovative methods for the potency evaluation of biologics. Today, the patent for the method used to assess cytolytic activity in biologics is extended to Canada, thus illustrating the growth of Clean Cells and its inherent assay development expertise.
Press Release
Clean Cells invests over €13M in new biopharmaceutical production site
5,300 m2 new facility will quadruple analysis and production capacity, becoming largest site in Europe for biopharmaceuticals quality control services and production of cell banks for innovative drugs.